DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Drugs and Biologics Logistics Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics logistics market as it emerges from the COVID -19 shut down.
The global pharmaceutical drugs and biologics logistics market reached a value of nearly $90,300.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.1% since 2015. The market is expected to reach $102,899.4 million by 2025, and $130,037.9 million by 2030.
Companies Mentioned
- FedEx
- UPS Inc.
- Kuehne + Nagel
- DB Schenker
- DSV Panalpina
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 14+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by type of service will arise in the non-cold chain logistics segment, which will gain $7,010.1 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by mode of transport will arise in the land transportation segment, which will gain $7,161.7 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by pharmaceutical type will arise in the pharmaceutical drugs segment, which will gain $8,597.0 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by therapeutic are will arise in the metabolic disorders drugs segment.
Market-trend-based strategies for the pharmaceutical drugs and biologics logistics market include acquiring new technologies and expertise, providing sea-based logistics services, focusing on patient-centric supply chains, using automated storage and retrieval systems, adopting advanced digital technologies, investing in reusable packaging, phase change materials, focusing on energy efficiency, and focusing on green supply chain management. Player-adopted strategies in the pharmaceutical drugs and biologics logistics market include expanding through strategic partnerships, and expanding through investing in building warehouses in different geographies.
To take advantage of the opportunities, the publisher recommends the pharmaceutical drugs and biologics logistics market companies to focus on acquiring companies, patient-centric supply chains, digitalization, investing in green supply chain management, expanding in emerging markets, provide competitively priced offerings, leverage social media, targeting distributors in emerging markets and collaboration with e-commerce companies.
Key Topics Covered
1. Pharmaceutical Drugs and Biologics Logistics Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation by Geography
6.2. Segmentation by Type
6.3. Segmentation by Mode of Transport
6.4. Segmentation by Pharmaceutical Type
6.5. Segmentation by Therapeutic Area
7. Pharmaceutical Drugs and Biologics Logistics Market Characteristics
7.1. Market Definition
7.2. Segmentation by Type of Service
7.3. Segmentation by Mode of Transport
7.4. Segmentation by Pharmaceutical Type
7.5. Segmentation by Therapeutic Area
8. Pharmaceutical Drugs and Biologics Logistics Market Customer Information
9. Pharmaceutical Drugs and Biologics Logistics PESTEL Analysis
10. Pharmaceutical Drugs and Biologics Logistics Porter's Five Forces Analysis
11. Pharmaceutical Drugs and Biologics Market Trends and Strategies
11.1. Increasing Consolidation in the Industry
11.2. Shift Towards Ocean Shipments
11.3. Automated Storage and Retrieval Systems
11.4. Patient-Centric Supply Chains
11.5. Blockchain and IoT in Pharmaceutical Logistics
11.6. Reusable Packaging for Shipping Pharmaceuticals
11.7. Phase Change Materials in Pharmaceutical Cold Chain
11.8. IATA Certification for Pharmaceutical Shipments
11.9. Green Supply Chain Management
11.10. Energy Efficiency
12. Impact of COVID-19 on the Pharmaceuticals and Biologics Logistics Market
12.1. Collaboration by Leading Players
12.2. Initiatives by Leading Players to Supply Covid-19 Vaccine and Other Pharmaceuticals
12.3. Government Intervention
13. Global Pharmaceutical Drugs and Biologics Logistics Market Size and Growth
13.1. Market Size
13.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14. Pharmaceutical Drugs and Biologics Logistics Market, Regional Analysis
14.1. Global Pharmaceutical Drugs and Biologics Logistics Market, by Region
14.2. Global Pharmaceutical Drugs and Biologics Logistics Market, by Country
15. Global Pharmaceutical Drugs and Biologics Logistics Market Segmentation
16. Global Pharmaceutical Drugs and Biologics Logistics Market Comparison with Macro Economic Factors
For more information about this report visit https://www.researchandmarkets.com/r/rqd9vb
